156 related articles for article (PubMed ID: 34184605)
21. Impact of PET reconstruction algorithm and threshold on dose painting of non-small cell lung cancer.
Knudtsen IS; van Elmpt W; Ollers M; Malinen E
Radiother Oncol; 2014 Nov; 113(2):210-4. PubMed ID: 25443496
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of tumour blood flow, [¹⁸F]EF5 and [¹⁸F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy.
Komar G; Lehtiö K; Seppänen M; Eskola O; Levola H; Lindholm P; Sipilä H; Seppälä J; Grénman R; Solin O; Minn H
Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2042-50. PubMed ID: 24898846
[TBL] [Abstract][Full Text] [Related]
23. 18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.
Komar G; Seppänen M; Eskola O; Lindholm P; Grönroos TJ; Forsback S; Sipilä H; Evans SM; Solin O; Minn H
J Nucl Med; 2008 Dec; 49(12):1944-51. PubMed ID: 18997048
[TBL] [Abstract][Full Text] [Related]
24. The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography.
Lin Z; Mechalakos J; Nehmeh S; Schoder H; Lee N; Humm J; Ling CC
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1219-28. PubMed ID: 18313529
[TBL] [Abstract][Full Text] [Related]
25. Feasibility and sensitivity study of helical tomotherapy for dose painting plans.
Deveau MA; Bowen SR; Westerly DC; Jeraj R
Acta Oncol; 2010 Oct; 49(7):991-6. PubMed ID: 20831487
[TBL] [Abstract][Full Text] [Related]
26. Simulated dose painting of hypoxic sub-volumes in pancreatic cancer stereotactic body radiotherapy.
Elamir AM; Stanescu T; Shessel A; Tadic T; Yeung I; Letourneau D; Kim J; Lukovic J; Dawson LA; Wong R; Barry A; Brierley J; Gallinger S; Knox J; O'Kane G; Dhani N; Hosni A; Taylor E
Phys Med Biol; 2021 Sep; 66(18):. PubMed ID: 34438383
[TBL] [Abstract][Full Text] [Related]
27. Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies.
Bollineni VR; Koole MJ; Pruim J; Brouwer CL; Wiegman EM; Groen HJ; Vlasman R; Halmos GB; Oosting SF; Langendijk JA; Widder J; Steenbakkers RJ
Radiother Oncol; 2014 Nov; 113(2):198-203. PubMed ID: 25434768
[TBL] [Abstract][Full Text] [Related]
28. FDG-PET and diffusion-weighted MRI in head-and-neck cancer patients: implications for dose painting.
Houweling AC; Wolf AL; Vogel WV; Hamming-Vrieze O; van Vliet-Vroegindeweij C; van de Kamer JB; van der Heide UA
Radiother Oncol; 2013 Feb; 106(2):250-4. PubMed ID: 23395065
[TBL] [Abstract][Full Text] [Related]
29. Dose painting by means of Monte Carlo treatment planning at the voxel level.
Jiménez-Ortega E; Ureba A; Vargas A; Baeza JA; Wals-Zurita A; García-Gómez FJ; Barbeiro AR; Leal A
Phys Med; 2017 Oct; 42():339-344. PubMed ID: 28412136
[TBL] [Abstract][Full Text] [Related]
30. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
[TBL] [Abstract][Full Text] [Related]
31. Impact of tumour motion compensation and delineation methods on FDG PET-based dose painting plan quality for NSCLC radiation therapy.
Thomas HM; Kinahan PE; Samuel JJE; Bowen SR
J Med Imaging Radiat Oncol; 2018 Feb; 62(1):81-90. PubMed ID: 29193781
[TBL] [Abstract][Full Text] [Related]
32. Invited editorial for the paper by Silvoniemi et al. "Repeatability of tumor hypoxia imaging using [
Koch CJ
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):159-160. PubMed ID: 29177538
[No Abstract] [Full Text] [Related]
33. Evaluating the impact of a rigid and a deformable registration method of pre-treatment images for hypoxia-based dose painting.
Lazzeroni M; Ureba A; Rosenberg V; Schäfer H; Rühle A; Baltas D; Toma-Dasu I; Grosu AL
Phys Med; 2024 Jun; 122():103376. PubMed ID: 38772061
[TBL] [Abstract][Full Text] [Related]
34. Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush.
Meijer G; Steenhuijsen J; Bal M; De Jaeger K; Schuring D; Theuws J
Radiother Oncol; 2011 Sep; 100(3):396-401. PubMed ID: 21955663
[TBL] [Abstract][Full Text] [Related]
35. Photon and Proton Dose Painting Based on Oxygen Distribution - Feasibility Study and Tumour Control Probability Assessment.
Ureba A; Ödén J; Toma-Dasu I; Lazzeroni M
Adv Exp Med Biol; 2022; 1395():223-228. PubMed ID: 36527641
[TBL] [Abstract][Full Text] [Related]
36. Feasibility of Multiparametric Positron Emission Tomography/Magnetic Resonance Imaging as a One-Stop Shop for Radiation Therapy Planning for Patients with Head and Neck Cancer.
Olin AB; Hansen AE; Rasmussen JH; Ladefoged CN; Berthelsen AK; Håkansson K; Vogelius IR; Specht L; Gothelf AB; Kjaer A; Fischer BM; Andersen FL
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1329-1338. PubMed ID: 32682955
[TBL] [Abstract][Full Text] [Related]
37. Positron emission tomography guided dose painting by numbers of lung cancer: Alanine dosimetry in an anthropomorphic phantom.
Papoutsis I; Skjei Knudtsen I; Peter Skaug Sande E; Louni Rekstad B; Öllers M; van Elmpt W; Røthe Arnesen M; Malinen E
Phys Imaging Radiat Oncol; 2022 Jan; 21():101-107. PubMed ID: 35243040
[TBL] [Abstract][Full Text] [Related]
38. Combined RBE and OER optimization in proton therapy with FLUKA based on EF5-PET.
Henjum H; Dahle TJ; Mairani A; Pilskog S; Stokkevåg C; Boer CG; Redalen KR; Minn H; Malinen E; Ytre-Hauge KS
J Appl Clin Med Phys; 2023 Sep; 24(9):e14014. PubMed ID: 37161820
[TBL] [Abstract][Full Text] [Related]
39. Non-invasive evaluation of tumour hypoxia in the Shionogi tumour model for prostate cancer with 18F-EF5 and positron emission tomography.
Yapp DT; Woo J; Kartono A; Sy J; Oliver T; Skov KA; Koch CJ; Adomat H; Dragowska WH; Fazli L; Ruth T; Adam MJ; Green D; Gleave M
BJU Int; 2007 May; 99(5):1154-60. PubMed ID: 17309552
[TBL] [Abstract][Full Text] [Related]
40. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
